Skip to main content

Peer Review reports

From: Central effects of galcanezumab in migraine: a pilot study on Steady State Visual Evoked Potentials and occipital hemodynamic response in migraine patients

Original Submission
21 Mar 2022 Submitted Original manuscript
27 Mar 2022 Reviewed Reviewer Report
30 Mar 2022 Reviewed Reviewer Report
7 Apr 2022 Author responded Author comments - Marina de Tommaso
Resubmission - Version 2
7 Apr 2022 Submitted Manuscript version 2
11 Apr 2022 Editorially accepted
29 Apr 2022 Article published 10.1186/s10194-022-01421-z

You can find further information about peer review here.

Back to article page